The European Patent Office (EPO) and participating European Union countries are in the final stages of establishing the Unitary Patent…
Read MoreTag: intellectualproperty
Filter By
Priscilla Makovski announces retirement after 44 years at Barker Brettell
Today we announce that Priscilla Makovski will be retiring after 44 years at Barker Brettell. Priscilla was managing partner between…
Read MoreGetting noticed: employing Intellectual Property to open doors and expand your business network
Patent attorney and partner Dave Combes will be attending the FAC Annual Conference on 25 November 2021. An expert in…
Read MoreCopy That: IPM Magazine November 2021 featured article
What can the FMGC sector do to protect its branded products against copycats? Carole Drury, associate patent attorney at Barker…
Read MoreRetaining brand values behind closed doors
As the coronavirus tsunami crashed through the economy, wiping an estimated £1.7bn off the UK cosmetics and toiletries industry in…
Read MoreEPO’s Enlarged Board of Appeal to give guidance on timings of data submission
In some fields – such as chemistry, biology and physics – results are not totally predictable. However, it can be…
Read MoreAct now to continue IP protection in the UK: Brexit transition period for EU trade marks and designs ends on the 30th September 2021
Following the UK’s departure from the EU on the 31st December 2020, the end of the transition period is now…
Read MoreDesigning and driving a career path in Intellectual Property
A passion for automotive Design rights, relishing representing clients as an IP Higher Courts Litigator, and striking a good work-life…
Read MoreOnline seminar: UK Design rights in a post-Brexit world
Register for free here to attend an online presentation by Carrie Johnson, head of the designs and copyright team at…
Read MoreKeeping electric cars green: battery recycling innovation
Electric cars are great for eliminating at-vehicle emissions, but, even with a 10-20 year battery life-span, it will not be…
Read MoreThe verdict is in: it’s a yes from the FDA for the controversial Alzheimer’s drug, after a tricky year for Biogen
The pharmaceutical industry has eagerly awaited the decision from the US Food and Drug Administration (FDA) on the first new…
Read MoreKeeping in line: intraoperative surgical guidance innovation
Surgery is, by its very nature, an invasive procedure. It can be transformative to the quality of life of those…
Read More